Literature DB >> 21451446

Tetanus surveillance --- United States, 2001-2008.

.   

Abstract

Tetanus is a life-threatening but preventable disease caused by the toxin of Clostridium tetani, a ubiquitous, spore-forming, gram-positive bacillus found in high concentrations in soil and animal excrement. Reported tetanus cases have declined >95%, and deaths from tetanus have declined >99% in the United States since 1947, when the disease became reportable nationally. To update a previous report and to determine the populations at greatest risk for the disease, CDC analyzed cases reported to the National Notifiable Diseases Surveillance System (NNDSS) during 2001--2008. This report summarizes the results of that analysis, which found that 233 tetanus cases were reported during 2001--2008; among the 197 cases with known outcomes, the case-fatality rate was 13.2%. Average annual incidence during that period was 0.10 per 1 million population overall and 0.23 among persons aged ≥65 years. Incidence among Hispanics was nearly twice that among non-Hispanics, a difference accounted for by 16 cases among Hispanic injection drug users (IDUs). Among the 92 patients for whom tetanus toxoid-containing (TT) vaccination status was available, 37 (40.2%) had received no doses of TT vaccine. Thirty (15.4%) of 195 patients had diabetes, and 27 (15.3%) of 176 were IDUs. Of 51 patients with an acute wound and a surveillance report complete enough to evaluate tetanus prophylaxis, 49 (96.1%) had not received appropriate prophylaxis. Tetanus remains a rare but life-threatening disease in the United States. Health-care providers should ensure up-to-date TT vaccination of all their patients, especially persons aged ≥65 years, persons with diabetes, and injection drug users.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21451446

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  35 in total

1.  The Effect of Pharmacy-Driven Education on the Amount of Appropriately Administered Tetanus Vaccines in the Emergency Department.

Authors:  Meghan Fletcher; Shannon Rankin; Preeyaporn Sarangarm
Journal:  Hosp Pharm       Date:  2018-04-18

Review 2.  Vaccination in the elderly: what can be recommended?

Authors:  Pierre-Olivier Lang; Richard Aspinall
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

3.  Durability of Vaccine-Induced Immunity Against Tetanus and Diphtheria Toxins: A Cross-sectional Analysis.

Authors:  Erika Hammarlund; Archana Thomas; Elizabeth A Poore; Ian J Amanna; Abby E Rynko; Motomi Mori; Zunqiu Chen; Mark K Slifka
Journal:  Clin Infect Dis       Date:  2016-03-21       Impact factor: 9.079

4.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

5.  Factors Related to Pertussis and Tetanus Vaccination Status Among Foreign-Born Adults Living in the United States.

Authors:  Liliana Sánchez-González; Alfonso Rodriguez-Lainz; Alissa O'Halloran; Ali Rowhani-Rahbar; Jennifer L Liang; Peng-Jun Lu; Peter M Houck; Stephane Verguet; Walter W Williams
Journal:  J Community Health       Date:  2017-06

6.  Return of the old guard: a case of tetanus in an unvaccinated patient.

Authors:  Uzochukwu Ibe; Sameerah Rehmani; Nasheena Jiwa; Arjet Gega
Journal:  BMJ Case Rep       Date:  2019-06-26

Review 7.  Approach to preventive care in the elderly.

Authors:  Bachir Tazkarji; Robert Lam; Shawn Lee; Soumia Meiyappan
Journal:  Can Fam Physician       Date:  2016-09       Impact factor: 3.275

8.  National and State-Specific Td and Tdap Vaccination of Adult Populations.

Authors:  Peng-Jun Lu; Alissa O'Halloran; Helen Ding; Jennifer L Liang; Walter W Williams
Journal:  Am J Prev Med       Date:  2015-11-29       Impact factor: 5.043

9.  Tetanus and diphtheria immunity in refugees in Europe in 2015.

Authors:  Alexandra Jablonka; Georg M N Behrens; Marcus Stange; Christian Dopfer; Ulrike Grote; Gesine Hansen; Reinhold Ernst Schmidt; Christine Happle
Journal:  Infection       Date:  2016-08-19       Impact factor: 3.553

Review 10.  Recommendations and barriers to vaccination in systemic lupus erythematosus.

Authors:  Megha Garg; Naaima Mufti; Tara N Palmore; Sarfaraz A Hasni
Journal:  Autoimmun Rev       Date:  2018-08-11       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.